J Clin Microbiol 2004,42(9):4040–4049.PubMedCrossRef 4. Constant P, Perez E, Malaga W, Laneelle MA, Saurel O, Daffe M, Guilhot C: Role of the pks15/1 gene in the biosynthesis of phenolglycolipids in the Mycobacterium tuberculosis

complex. Evidence that all strains synthesize glycosylated p-hydroxybenzoic methyl Temsirolimus esters and that strains devoid of phenolglycolipids harbor a frameshift mutation in the pks15/1 gene. J Biol Chem 2002,277(41):38148–38158.PubMedCrossRef 5. Tsolaki AG, Gagneux S, Pym AS, Goguet de la Salmoniere YO, Kreiswirth BN, Van Soolingen D, Small PM: Genomic deletions classify the Beijing/W strains as a distinct genetic lineage of Mycobacterium tuberculosis. J Clin Microbiol 2005,43(7):3185–3191.PubMedCrossRef click here 6. Bifani PJ, Mathema B, Kurepina NE, Kreiswirth BN: Global dissemination of the Mycobacterium tuberculosis W-Beijing family strains. selleck products Trends Microbiol 2002,10(1):45–52.PubMedCrossRef 7. Glynn JR, Whiteley J, Bifani PJ, Kremer K, van Soolingen D: Worldwide occurrence of Beijing/W strains of Mycobacterium tuberculosis: a systematic review. Emerg Infect Dis 2002,8(8):843–849.PubMed 8. European Concerted Action on new generation genetic markers and techniques

for the epidemiology and control of Tuberculosis. Beijing/W genotype Mycobacterium tuberculosis and drug resistance Emerg Infect Dis 2006,12(5):736–743. 9. Samper S, Iglesias MJ, Rabanaque MJ, Gomez LI, Lafoz MC, Jimenez MS, Ortega A, Lezcano MA, Van Soolingen D, Martin C: Systematic molecular characterization of multidrug-resistant Mycobacterium tuberculosis complex isolates from Spain. J Clin Microbiol 2005,43(3):1220–1227.PubMedCrossRef 10. Theus SA, Cave many MD, Eisenach KD: Intracellular macrophage growth rates and cytokine profiles of Mycobacterium tuberculosis strains with different transmission dynamics. J Infect Dis 2005,191(3):453–460.PubMedCrossRef 11. Lopez B, Aguilar D, Orozco H, Burger M, Espitia C, Ritacco V, Barrera L, Kremer K, Hernandez-Pando R, Huygen K, et al.: A marked difference in pathogenesis and immune response induced by different Mycobacterium

tuberculosis genotypes. Clin Exp Immunol 2003,133(1):30–37.PubMedCrossRef 12. Reed MB, Domenech P, Manca C, Su H, Barczak AK, Kreiswirth BN, Kaplan G, Barry CE: A glycolipid of hypervirulent tuberculosis strains that inhibits the innate immune response. Nature 2004,431(7004):84–87.PubMedCrossRef 13. Manca C, Reed MB, Freeman S, Mathema B, Kreiswirth B, Barry CE, Kaplan G: Differential monocyte activation underlies strain-specific Mycobacterium tuberculosis pathogenesis. Infect Immun 2004,72(9):5511–5514.PubMedCrossRef 14. Caminero JA, Pena MJ, Campos-Herrero MI, Rodriguez JC, Garcia I, Cabrera P, Lafoz C, Samper S, Takiff H, Afonso O, et al.: Epidemiological evidence of the spread of a Mycobacterium tuberculosis strain of the Beijing genotype on Gran Canaria Island. Am J Respir Crit Care Med 2001,164(7):1165–1170.PubMed 15.